Alerts will be sent to your verified email
Verify Email
JUBLINGREA
|
Jubilant Ingrevia
|
Alivus Life Sciences
|
Aether Industries
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.84 % | 25.27 % | 12.44 % |
|
5yr Avg Net Profit Margin
|
6.89 % | 20.19 % | 17.79 % |
|
Price to Book
|
3.97 | 4.08 | 4.41 |
|
P/E
|
41.92 | 23.19 | 55.97 |
|
5yr Avg Cash Conversion Cycle
|
-3.44 Days | 100.66 Days | 173.8 Days |
|
5yr Average Interest Coverage Ratio
|
14.0 | 371.82 | 19.69 |
|
5yr Avg ROCE
|
13.27 % | 33.88 % | 15.21 % |
|
5yr Avg Operating Profit Margin
|
13.6 % | 29.64 % | 26.99 % |
|
5 yr average Debt to Equity
|
0.21 | 0.0 | 0.23 |
|
5yr CAGR Net Profit
|
35.81 % | 6.67 % | 7.78 % |
|
5yr Average Return on Assets
|
6.07 % | 14.28 % | 8.26 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
45.22 % | 74.94 % | 75.0 % |
|
Share Pledged by Promoters
|
2.22 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.25 % | -7.91 % | -12.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
19.5 % | 3.35 % | 4.9 % |
|
Jubilant Ingrevia
|
Alivus Life Sciences
|
Aether Industries
|
|---|